Clinical Topics & News

Superficial Pyoderma Gangrenosum Treated With Infliximab: A Case Report

Bhatti H, Khalid N, Rao B

We report a case of superficial pyoderma gangrenosum (SPG) that was successfully treated with infliximab. A 22-year-old man presented with several polycyclic, purplish red plaques with some crusting and well-defined edges on the bilateral lower extremities. Histology showed superficial and deep mixed inflammatory cell infiltrate with prominent neutrophils and scarring noted as a result of multiple sinus tract formations that were characteristic of SPG. After unsuccessful results with typical treatments (ie, steroids, antibiotics, immunosuppressants), the patient was successfully treated with infliximab.


 

Recommended Reading

Secukinumab Tames Hand, Foot Psoriasis
Psoriasis Collection
Oral JAK Inhibitor's Clinical Place To Be Determined
Psoriasis Collection
ACE Inhibitors Up Mortality Risk When Given Prior to Scleroderma Renal Crisis
Psoriasis Collection
Biologics May Reduce RA Patients' Risk of Early Death
Psoriasis Collection
Ustekinumab's Cardiovascular Event Rates Stable at 5 Years
Psoriasis Collection
Free Pharma Pens: The Skinny Podcast
Psoriasis Collection
Subcutaneous Nodules Linked to Cardiovascular Disease Risk in RA
Psoriasis Collection
Anti-Jo1 Predicts Improvement With Rituximab
Psoriasis Collection
Psoriasis Patients Have Low Rates of Common Cancers
Psoriasis Collection
308-nm UVB Excimer Laser Versus Nontargeted Phototherapy
Psoriasis Collection